Having stopped the usage of Johnson & Johnson’s (J&J) coronavirus (COVID-19) vaccine in all 50 US states the previous day, US Centers for Disease Control and Prevention (CDC) extends the pause on the usage of the vaccine amid a lack of more data to assess the risk.
The CDC panel concludes without a vote and plans to identify a date for the next meeting related to pausing the J&J covid-19 vaccine by Friday, which aims to reconvene in a week to 10 days.
It should, however, be noted that CDC director Dr. Rochelle Walensky said, per New York Post, “Blood clots reported in recipients of the Johnson & Johnson vaccine are “similar” to the adverse reaction linked to AstraZeneca’s shot in Europe.”
Elsewhere, Novavax to participate in University of Oxford com-cov2 study comparing mixed covid-19 vaccine combos. The study will explore heterologous regimen of covid-19 vaccines from different manufacturers.
FX reaction
Given the absence of fresh news, coupled with thin trading in Asia, global markets mostly ignore the news. However, the same signals challenge to the market sentiment and may weigh on S&P 500 Futures.
원저자가 모두 저작권을 보유한 FXStreet에서 재 인쇄 함.
면책 조항: 본 게시글에 표현된 견해는 전적으로 작성자의 견해이며 Followme의 공식 입장을 대변하지 않습니다. Followme는 제공된 정보의 정확성, 완전성 또는 신뢰성에 대해 책임을 지지 않으며, 서면으로 명시적으로 언급되지 않는 한 해당 내용을 기반으로 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다.
더 오래된 의견은 없습니다. 소파를 가장 먼저 잡으십시오.